Table 4

Results of ANCOVA models examining group differences in model parameters, when accounting for main effects and interactions with age and sex

Predictor*Test, p valueB (95% CI), p valuePost hoc contrasts*
Emotion conflict
AgeF1, 471 = 5.02, p = 0.0260 (−0.01 to 0.02), p = 0.569NS
SexF1, 471 = 2.41, p = 0.121−0.23 (−0.39 to −0.08), p = 0.002NS
GroupF1, 471 = 24.83, p < 0.001D/A: −0.17 (−0.36 to 0.03), p = 0.091
SUD: −0.53 (−0.72 to −0.34), p < 0.001
HC–D/A: 0.22, t471 = 2.33, p = 0.020
HC–SUD: 0.64, t471 = 6.75, p < 0.001
D/A–SUD: 0.42, t471 = 5.52, p < 0.001
Age × groupF2, 471 = 1.38, p = 0.253Age × D/A: 0 (−0.02 to 0.02), p = 0.916
Age × SUD: 0.01 (−0.01 to 0.03), p = 0.153
NS
Sex × groupF2, 471 = 5.55, p = 0.004Sex × D/A: 0.14 (−0.05 to 0.33), p = 0.144
Sex × SUD: 0.32 (0.13 to 0.51), p = 0.001
Male
HC–D/A: 0.02, t471 = 0.14, p = 0.887
HC–SUD: 0.21, t471 = 1.40, p = 0.163
D/A–SUD: 0.19, t471 = 1.36, p = 0.174
Female
HC–D/A: 0.31, t471 = 2.74, p = 0.007
HC–SUD: 0.85, t471 = 7.03, p < 0.001
D/A–SUD: 0.54, t471 = 5.77, p < 0.001
Decision uncertainty
AgeF1, 471 = 32.56, p < 0.0010.01 (−0.01 to 0.03), p = 0.27NS
SexF1, 471 = 3.28, p = 0.071−0.1 (−0.3 to 0.09), p = 0.301NS
GroupF1, 471 = 3.69, p = 0.026D/A: −0.02 (−0.27 to 0.23), p = 0.871
SUD: 0.26 (0.01 to 0.51), p = 0.042
HC–D/A: 0.02, t471 = 0.15, p = 0.884
HC–SUD: −0.24, t471 = −1.94, p = 0.053
D/A–SUD: −0.26, t471 = −2.57, p = 0.011
Age × groupF2, 471 = 3.71, p = 0.025Age × D/A: 0.02 (−0.01 to 0.04), p = 0.155
Age × SUD: 0.03 (0.01 to 0.06), p = 0.007
HC–D/A: −0.02, t471 = −1.42, p = 0.155
HC–SUD: −0.04, t471 = −2.72, p = 0.007
D/A–SUD: −0.02, t471 = −1.66, p = 0.097
Sex × groupF2, 471 = 0.17, p = 0.847Sex × D/A: −0.01 (−0.26 to 0.24), p = 0.941
Sex × SUD: 0.05 (−0.2 to 0.3), p = 0.688
NS
  • ANCOVA = analysis of covariance; CI = confidence interval; D/A = depression/anxiety disorder group; HC = healthy control group; NS = nonsignificant; SUD = substance use disorder group.

  • * For interpretability, continuous predictors were centred, sum coding was used for sex (female = −1; male = 1), and treatment coding was used for group (with healthy controls as the reference group, coded as 0).